Chugai Pharmaceutical Co., Ltd. (FRA:CUP)
Germany flag Germany · Delayed Price · Currency is EUR
52.02
-0.50 (-0.95%)
At close: Mar 9, 2026

Chugai Pharmaceutical Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
426,602540,202458,674222,169267,753
Upgrade
Short-Term Investments
553,094456,143280,308280,938204,217
Upgrade
Cash & Short-Term Investments
979,696996,345738,982503,107471,970
Upgrade
Cash Growth
-1.67%34.83%46.88%6.60%24.65%
Upgrade
Accounts Receivable
442,876334,256318,892512,538355,081
Upgrade
Other Receivables
2368961,4561,745928
Upgrade
Receivables
443,112335,152320,348514,283356,009
Upgrade
Inventory
276,848240,067273,480292,206208,838
Upgrade
Prepaid Expenses
-23,01321,82718,77017,301
Upgrade
Other Current Assets
41,10211,46611,7898,1719,543
Upgrade
Total Current Assets
1,740,7581,606,0431,366,4261,336,5371,063,661
Upgrade
Property, Plant & Equipment
479,481441,554420,701386,651352,107
Upgrade
Long-Term Investments
-73,07361,08656,18544,663
Upgrade
Other Intangible Assets
54,53917,86819,86025,14121,974
Upgrade
Long-Term Deferred Tax Assets
88,30469,83564,47465,24456,287
Upgrade
Other Long-Term Assets
105,513---2
Upgrade
Total Assets
2,468,5952,208,3731,932,5471,869,7581,538,694
Upgrade
Accounts Payable
127,24765,353112,468209,835152,266
Upgrade
Accrued Expenses
-49,32444,62937,75134,421
Upgrade
Current Portion of Leases
-6,3656,9756,4346,550
Upgrade
Current Income Taxes Payable
91,004142,49971,573121,160108,293
Upgrade
Current Unearned Revenue
-31317986
Upgrade
Other Current Liabilities
192,82526,78552,54148,47125,806
Upgrade
Total Current Liabilities
411,076290,357288,217423,730327,422
Upgrade
Long-Term Leases
-4,5326,4807,6759,490
Upgrade
Pension & Post-Retirement Benefits
4,2453,9353,1463,3112,945
Upgrade
Long-Term Deferred Tax Liabilities
4,0155,0765,7877,0867,614
Upgrade
Other Long-Term Liabilities
23,5272,9743,3373,5693,206
Upgrade
Total Liabilities
442,863306,874306,967445,371350,677
Upgrade
Common Stock
73,20273,20273,20273,20273,202
Upgrade
Additional Paid-In Capital
70,51569,89669,35568,80668,223
Upgrade
Retained Earnings
1,890,0411,746,9341,488,7381,293,3521,054,050
Upgrade
Comprehensive Income & Other
-8,02611,467-5,715-10,973-7,458
Upgrade
Total Common Equity
2,025,7321,901,4991,625,5801,424,3871,188,017
Upgrade
Shareholders' Equity
2,025,7321,901,4991,625,5801,424,3871,188,017
Upgrade
Total Liabilities & Equity
2,468,5952,208,3731,932,5471,869,7581,538,694
Upgrade
Total Debt
-10,89713,45514,10916,040
Upgrade
Net Cash (Debt)
979,696985,448725,527488,998455,930
Upgrade
Net Cash Growth
-0.58%35.83%48.37%7.25%24.12%
Upgrade
Net Cash Per Share
595.30598.82440.92297.20277.12
Upgrade
Filing Date Shares Outstanding
1,6461,6461,6451,6451,644
Upgrade
Total Common Shares Outstanding
1,6461,6461,6451,6451,644
Upgrade
Working Capital
1,329,6821,315,6861,078,209912,807736,239
Upgrade
Book Value Per Share
1230.911155.56988.01865.88722.50
Upgrade
Tangible Book Value
1,971,1931,883,6311,605,7201,399,2461,166,043
Upgrade
Tangible Book Value Per Share
1197.771144.70975.94850.59709.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.